SAVA FY 2016 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$58,000

Operating Income

-$15M

Net Income

-$15M

EPS (Diluted)

$-2.28

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$19M

Total Liabilities

$665,000

Stockholders' Equity

$19M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$58,000	-$45,000	-28.9%
Operating Income	-$15M	-$14M	-5.3%
Net Income	-$15M	-$14M	-5.0%